Long-term speech and language developmental issues among children with Duarte galactosemia

Genetics in Medicine

Volumn 11, Issue 12, 2009, Pages 874-879

  Powell, Kimberly K ^a   Van Naarden Braun, Kim ^a   Singh, Rani H ^b   Shapira, Stuart K ^c   Olney, Richard S ^b,c   Yeargin Allsopp, Marshalyn ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Developmental disabilities; Duarte galactosemia; Newborn screening; Population based; Speech and language disorder

Indexed keywords

ARTICLE; AUTISM; CEREBRAL PALSY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DUARTE GALACTOSEMIA; GALACTOSEMIA; HEALTH SURVEY; HEARING LOSS; HUMAN; INFANT; INTELLECTUAL IMPAIRMENT; LANGUAGE DISABILITY; MAJOR CLINICAL STUDY; NEWBORN; PRESCHOOL CHILD; SCHOOL CHILD; SPECIAL EDUCATION; SPEECH DISORDER; VISUAL IMPAIRMENT;

ADOLESCENT; AUTISTIC DISORDER; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DEVELOPMENTAL DISABILITIES; EDUCATION, SPECIAL; GALACTOSEMIAS; GEORGIA; HEARING LOSS; HUMANS; INFANT; INFANT, NEWBORN; LANGUAGE DEVELOPMENT DISORDERS; NEONATAL SCREENING; POPULATION SURVEILLANCE; SPEECH DISORDERS; TIME FACTORS; VISION, LOW;

EID: 73849129113     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181c0c38d     Document Type: Article

References (20)

1. Suzuki M, West C, Beutler E. Large-scale molecular screening for galac-tosemia alleles in a pan-ethnic population. Hum Genet 2001;109:210-215.
2. Elsas L, Dembure P, Langley S, Paulk E, Hjelm L, Fridovich-Keil J. A common mutation associated with the Duarte galactosemia allele. Am J Hum Genet 1994;54:1030-1036.
3. Waggoner D, Buist N, Donnell G. Long-term prognosis in galactosemia: results of a survey of 350 cases. J Inherit Metab Dis 1990;13:802-808.
4. Schweitzer S, Shin Y, Jakobs C, Brodehl J. Long-term outcome in 134 patients with galactosemia. Eur J Pediatr 1993;152:36-43.
5. Levy HL, Spe SJ, Walton DS, et al. Galactose-1-phosphate uridyl transferase deficiency due to Duarte/galactosemia combined variation: clinical and biochemical studies. J Pediatr 1978;92:390-393.
6. Schwarz HP, Zuppinger KA, Zimmerman A, Dauwalder H, Scherz R, Bier DM. Galactose intolerance in individuals with double heterozygosity for the Duarte variant and galactosemia. J Pediatr 1982;100:704-749.
7. Kelly S. Significance of the Duarte/classical galactosemia genetic compound. J Pediatr 1979;94:937-940.
8. Gitzelmann R, Bosshard NU. Partial deficiency of galactose-1-phosphate uridyl transferase. Eur J Pediatr 1995;154:S40-S44.
9. Kamphaus R. Clinical assessment of child and adolescent intelligence, 2nd ed. Boston: Allyn & Bacon, 2001:64-70.
10. Ficicioglu C, Thomas N, Yager C, et al. Duarte (DG) galactosemia: a pilot study of biochemical and neurodevelopmental assessment in children detected by newborn screening. Mol Genet Metab 2008;95:206-212.
11. Beutler E, Baluda MC. A simple spot screening test for galactosemia. J Lab Clin Med 1966;68:137-141.
12. Hochella NJ, Hill JB. Fluorometric screening for galactosemia utilizing the autoanalyzer. Clin Chem 1969;10:949-960.
13. Bhasin T, Brocksen S, Avchen R, Van Naarden Braun K. Prevalence of four developmental disabilities among children aged 8 years\-Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1996 and 2000. MMWR Surveill Summ 2006;55:1-9.
14. Van Naarden Braun K, Yeargin-Allsopp M, Schendel D, Fernhoff P. Long-term developmental outcomes of children identified through a newborn screening program with a metabolic or endocrine disorder: a population-based approach. J Pediatr 2003;143:236-242.
15. Waisbren SE, Norman TR, Schnell RR, Levy HL. Speech and language deficits in early treated children with galactosemia. J Pediatr 1983;102: 75-77.
16. Nelson CD, Waggoner DD, Donnell GN, Tuerck JM, Buist NR. Verbal dyspraxia in treated galactosemia. Pediatrics 1991;88:346-350.
17. Robertson A, Singh RH, Guerrero NV, Hundley M, Elsas LJ. Outcomes analysis of verbal dyspraxia in classic galactosemia. Genet Med 2000;2:142-148.
18. Ridel KR, Leslie ND, Gilbert DL. An updated review of the long-term neurological effects of galactosemia. Pediatr Neurol 2005;33:153-161.
19. Rice CE, Baio J, Van Naarden Braun K, Doernberg N, Meaney FJ, Kirby RS; ADDM Network. A public health collaboration for the surveillance of autism spectrum disorders. Paediatr Perinat Epidemiol 2007;21:179-190.
20. Kemper AR, Boyle CA, Aceves J, et al. Long-term follow-up after diagnosis resulting from newborn screening: statement of the US Secretary of Health and Human Services' Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children. Genet Med 2008;10:259-261. (Pubitemid 351544127)